In terms of Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, Welcure Drugs & Pharmaceuticals has informed that it enclosed the certificate received from Link Intime India (herein called as 'RTA') for the Quarter ended June 30, 2022.
The above information is a part of company’s filings submitted to BSE.